Taiwan Health Department Delegation Visits EGA

The EGA was recently honoured with a visit by an official delegation from the Bureau of Pharmaceutical Affairs, Department of Health, Taiwan.

Mr Greg Perry, EGA Director General, and Ms Suzette Kox, Senior Director Scientifc Affairs, meet with representatives of the Taiwanese government on Thursday, 9 June 2005. Discussions focussed on implementation of the new EU pharmaceutical legislation and its implications on access to cost-effective generic medicines in Europe.

The Tawainese officials were particularly keen to learn more about the new legal framework for generics adopted during last year’s Pharma Review, especially the provisions on data exclusivity and the European legal framework for biosimilar medicines.

At the end of what was an interesting and fruitful exchange, the delegation extended a warm invitation to the EGA to return the visit to the Department of Health in Taiwan.

Pictured in the photograph above are (left to right): Ms Suzette Kox, EGA Senior Director Scientific Affairs; Mr Greg Perry, Director General EGA, Dr Hong-Shou Yu, Senior Researcher and Dr Lun-Huei Lin, Researcher, both from the Bureau of Pharmaceutical Affairs, Department of Health, Taiwan and Hsiao-Ping Hsieh, Commercial Secretary Economic Division from the Taipei Representative Office in Belgium.